Join Here   |   Log In

IL-17: Chronic Inflammation & Autoimmune Risk with IL17A, IL17F

Key takeaways:
~IL-17 is a proinflammatory cytokine produced by T cells, including Th17 cells.
~ IL-17 is produced to fight off pathogens, such as tuberculosis or
~ Some people have a more sensitive immune system and are more prone to inflammatory reactions. Variants in the  IL17 genes are part of this. Members will see their genotype report below and the solutions in the Lifehacks section. Consider joining today

Inflammation and IL-17:

Interleukin-17 (IL17) is a pro-inflammatory cytokine produced by T-helper cells. It is part of our immune system — necessary in times of injury or pathogenic infection but problematic if overactive.[ref]

A quick overview of the immune system:

Our immune system’s composition includes many different parts and is responsible for both fighting off foreign pathogens (bacteria, viruses, etc.) and clearing out old or defective cells in the body. Thus, the immune system needs to recognize which cells are pathogens and which cells are part of the body. T-cells, also called T-lymphocytes, are a type of white blood cell that seek out and destroy pathogens. There are two types of T-cells, T-helper cells and T-effector cells. T helper cells help to organize the immune response against a pathogen.

Going a little deeper here… multiple types of T-helper cells secrete different cytokines needed for different types of immune responses. One of the T-helper cells is Th17, which secretes the inflammatory cytokine IL-17 (interleukin-17).[ref]

IL-17 in Inflammation and Autoimmunity:

IL-17, produced by Th17, is important in eliminating bacteria and fungi both inside and outside cells.[ref]

IL-17 has six different subtypes, from IL-17A to IL-17F. As inflammatory signaling molecules, both IL-17A and IL-17F act on the same receptor (IL-17R).

The IL-17 receptor is found in a variety of different cell types, and by activating the receptor, a number of different pro-inflammatory responses can happen. For example, in fungal infections, IL17 signaling can directly increase ROS production to fight off the fungus.[ref]

IL-17 signaling and receptors. From PMC10564932 (open access article, CC)

One of the main roles of IL17 is to protect ‘barrier integrity’ – the body’s front line against outside invaders. This means that the IL-17 receptor is found in skin tissue, mucosal tissue, the lungs, and other epithelial cells, such as those lining the intestines. One role of IL-17 is to maintain the tight junctions between the epithelial cells, and another action is to induce the release of antimicrobial chemokines in response to pathogens.[ref]

IL-17 is important in the defense against tuberculosis (Mycobacterium tuberculosis) and Staph infections on the skin. It is also important in fighting off fungal infections, such as Candida albicans. IL-17 is also important in your body’s defense against whooping cough.[ref] Thus, genetic variants that increased IL-17 were likely an advantage historically, when tuberculosis and pertussis were significant and common threats.

Increased risk for autoimmune diseases:

The flip side of this awesome fighter of pathogens is that IL-17 can cause damage to your tissues if it is too active. Research shows that IL-17 genetic variants can be a causative factor in several different autoimmune diseases.[ref][ref]

IL-17 is implicated in increasing the risk for several autoimmune diseases, including psoriasis, Hashimoto’s, and asthma. As mentioned above, IL-17 is mainly active in the epithelial and mucosal regions (lungs, gastrointestinal tract, skin), which explains its role in psoriasis, asthma, and other related conditions.

Genetic variants that increase the body’s production of IL-17A are a risk factor for inflammatory bowel disease (IBD), psoriasis, rheumatoid arthritis, bronchitis severity, gastric cancer, and more.

IL-17A is also implicated in celiac disease, with increased expression of IL-17A found in the intestinal mucosa of Celiac patients. Gluten sensitivity, though, was not found to increase IL-17A.[ref][ref]

Chronic itching:

IL-17A interacts with your skin microbiome, causing inflammation that drives itching. A 2025 study found that “during inflammation, IL-17A, a response associated with adaptive immunity to the skin microbiota, directly promotes cutaneous hyperinnervation. This process activates regenerative programs within neurons which become maladaptive upon inflammation.”  The specific skin bacterium used in the study was Staphylococcus aureus.[ref]


IL-17 Genotype Report

There are genetic variations in IL-17, causing it to be either more active than normal (increasing risk of autoimmune/inflammatory conditions) – OR – less active than normal (protective against autoimmune/inflammatory conditions).

As is almost always the case, diet and environment interact with genetics in the development of chronic diseases. Thus, just carrying the variant doesn’t cause inflammatory diseases, per se, but instead increases the susceptibility to them in conjunction with other factors.

Access this content:

An active subscription is required to access this content.

Join as a member


 


Lifehacks for decreasing high IL-17

Balance is key with the immune response – excess IL-17 is linked to autoimmune and inflammatory conditions, but IL-17 is also important in fighting off specific pathogens.

If you have an increased IL-17 response that is exacerbating an inflammatory condition, you may want to look into natural ways to decrease IL-17.

Keep in mind that tamping down IL-17 may not be a good idea if you’re also trying to fight off a pathogen. Talk with your doctor if you have any questions about supplements and their interactions with medications.

Dietary Changes that Impact IL-17:

Salt increases IL-17:
Studies in mice show that a high-salt diet can increase the differentiation of Th17 cells and thus increase IL-17.[ref] If you have an autoimmune disease, track how much salt you get in your diet and talk with your doctor about whether you should try a low-salt diet.

Sprinkle on the spices:
Ursolic acid, which is a natural carboxylic acid found in rosemary and thyme, is a strong inhibitor of IL-17.[ref] It is also a component of rosemary extract, which was traditionally used for treating rashes, wounds, dyspepsia, etc.[ref]

Vitamin C appears to upregulate IL-17, which may be good when fighting off a pathogen.[ref] Some vitamin C is essential for your health and a complete lack of vitamin C results in scurvy. However, if you have an autoimmune disease related to high IL-17, you may want to take this as a heads-up to be on the alert for increased symptoms if supplementing with vitamin C.

An apple a day?
Apples contain high concentrations of procyanidin B1 and B2, which inhibit the production of IL17.[ref]

Statins and IL-17:

Statins can inhibit IL-17 secretion. This may be helpful in autoimmune diseases that are driven by IL-17, but it also may interact with the ability of IL-17 to fight off certain pathogens. [ref]

7 Natural supplements that decrease IL-17:

Access this content:

An active subscription is required to access this content.

Join as a member



Related Articles and Topics:

Psoriasis Genes: How genetics point to individualized solutions

TNF-alpha: Inflammation, Chronic Diseases, and Genetic Susceptibility


References:

Abusleme, Loreto, and Niki M. Moutsopoulos. “IL-17; Overview and Role in Oral Immunity and Microbiome.” Oral Diseases, vol. 23, no. 7, Oct. 2017, pp. 854–65. PubMed Central, https://doi.org/10.1111/odi.12598.
Andrade, Joana M., et al. “Rosmarinus Officinalis L.: An Update Review of Its Phytochemistry and Biological Activity.” Future Science OA, vol. 4, no. 4, Feb. 2018, p. FSO283. PubMed Central, https://doi.org/10.4155/fsoa-2017-0124.
Arisawa, Tomiyasu, et al. “The Influence of Polymorphisms of Interleukin-17A and Interleukin-17F Genes on the Susceptibility to Ulcerative Colitis.” Journal of Clinical Immunology, vol. 28, no. 1, Jan. 2008, pp. 44–49. PubMed, https://doi.org/10.1007/s10875-007-9125-8.
Bao, Mei-Hua, et al. “Meta-Analysis for the Association between Polymorphisms in Interleukin-17A and Risk of Coronary Artery Disease.” International Journal of Environmental Research and Public Health, vol. 13, no. 7, July 2016, p. 660. PubMed Central, https://doi.org/10.3390/ijerph13070660.
Cantorna, Margherita T., et al. “Vitamin D and 1,25(OH)2D Regulation of T Cells.” Nutrients, vol. 7, no. 4, Apr. 2015, pp. 3011–21. PubMed, https://doi.org/10.3390/nu7043011.
Cascão, R., et al. “Effective Treatment of Rat Adjuvant-Induced Arthritis by Celastrol.” Autoimmunity Reviews, vol. 11, no. 12, Oct. 2012, pp. 856–62. PubMed Central, https://doi.org/10.1016/j.autrev.2012.02.022.
Chang, Seon Hee, and Chen Dong. “IL-17F: Regulation, Signaling and Function in Inflammation.” Cytokine, vol. 46, no. 1, Apr. 2009, pp. 7–11. PubMed Central, https://doi.org/10.1016/j.cyto.2008.12.024.
Cua, Daniel J., and Cristina M. Tato. “Innate IL-17-Producing Cells: The Sentinels of the Immune System.” Nature Reviews Immunology, vol. 10, no. 7, July 2010, pp. 479–89. www.nature.com, https://doi.org/10.1038/nri2800.
Delaleu, Jeremie, et al. “Maladaptive Immunity to the Microbiota Promotes Neuronal Hyperinnervation and Itch via IL-17A.” Proceedings of the National Academy of Sciences, vol. 122, no. 52, Dec. 2025, p. e2525146122. DOI.org (Crossref), https://doi.org/10.1073/pnas.2525146122.
Du, Jin, et al. “Single-Nucleotide Polymorphisms of IL-17 Gene Are Associated with Asthma Susceptibility in an Asian Population.” Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, vol. 22, Mar. 2016, pp. 780–87. PubMed, https://doi.org/10.12659/msm.895494.
Eskandari-Nasab, Ebrahim, Mehdi Moghadampour, Arezoo Tahmasebi, et al. “Interleukin-17 A and F Gene Polymorphisms Affect the Risk of Tuberculosis: An Updated Meta-Analysis.” The Indian Journal of Tuberculosis, vol. 65, no. 3, July 2018, pp. 200–07. PubMed, https://doi.org/10.1016/j.ijtb.2017.08.027.
———. “Meta-Analysis of Risk Association Between Interleukin-17A and F Gene Polymorphisms and Inflammatory Diseases.” Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research, vol. 37, no. 4, Apr. 2017, pp. 165–74. PubMed, https://doi.org/10.1089/jir.2016.0088.
Gao, Jie-Fang, et al. “Associations of the IL-17A Rs2275913 and IL-17F Rs763780 Polymorphisms with the Risk of Digestive System Neoplasms: A Meta-Analysis.” International Immunopharmacology, vol. 67, Feb. 2019, pp. 248–59. PubMed, https://doi.org/10.1016/j.intimp.2018.12.016.
Hawkes, Jason E., et al. “Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.” Journal of Immunology (Baltimore, Md.: 1950), vol. 201, no. 6, Sept. 2018, pp. 1605–13. PubMed, https://doi.org/10.4049/jimmunol.1800013.
Huangfu, Longjie, et al. “The IL-17 Family in Diseases: From Bench to Bedside.” Signal Transduction and Targeted Therapy, vol. 8, Oct. 2023, p. 402. PubMed Central, https://doi.org/10.1038/s41392-023-01620-3.
Keramat, Fariba, et al. “Association of Interleukin-17 Gene Polymorphisms and Susceptibility to Brucellosis in Hamadan, Western Iran.” Microbiology and Immunology, vol. 63, nos. 3–4, Mar. 2019, pp. 139–46. PubMed, https://doi.org/10.1111/1348-0421.12675.
Kitabayashi, Chika, et al. “Zinc Suppresses Th17 Development via Inhibition of STAT3 Activation.” International Immunology, vol. 22, no. 5, May 2010, pp. 375–86. PubMed, https://doi.org/10.1093/intimm/dxq017.
Lee, Young Ho, and Sang-Cheol Bae. “Associations between Circulating IL-17 Levels and Rheumatoid Arthritis and between IL-17 Gene Polymorphisms and Disease Susceptibility: A Meta-Analysis.” Postgraduate Medical Journal, vol. 93, no. 1102, Aug. 2017, pp. 465–71. PubMed, https://doi.org/10.1136/postgradmedj-2016-134637.
Li, Dapeng, et al. “Th17 Cell Plays a Role in the Pathogenesis of Hashimoto’s Thyroiditis in Patients.” Clinical Immunology (Orlando, Fla.), vol. 149, no. 3, Dec. 2013, pp. 411–20. PubMed, https://doi.org/10.1016/j.clim.2013.10.001.
Li, Wei, et al. “Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population.” Pharmacogenomics and Personalized Medicine, vol. 13, Dec. 2020, pp. 725–33. PubMed Central, https://doi.org/10.2147/PGPM.S275073.
Liang, Jie, et al. “Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting Glutathione.” Frontiers in Immunology, vol. 9, Nov. 2018, p. 2584. PubMed Central, https://doi.org/10.3389/fimmu.2018.02584.
Marwa, Ouled Salah, et al. “Association of IL17A and IL17F Genes with Rheumatoid Arthritis Disease and the Impact of Genetic Polymorphisms on Response to Treatment.” Immunology Letters, vol. 183, Mar. 2017, pp. 24–36. PubMed, https://doi.org/10.1016/j.imlet.2017.01.013.
Milovanovic, Jelena, et al. “Interleukin-17 in Chronic Inflammatory Neurological Diseases.” Frontiers in Immunology, vol. 11, June 2020, p. 947. PubMed Central, https://doi.org/10.3389/fimmu.2020.00947.
———. “Interleukin-17 in Chronic Inflammatory Neurological Diseases.” Frontiers in Immunology, vol. 11, June 2020, p. 947. PubMed Central, https://doi.org/10.3389/fimmu.2020.00947.
Office of Dietary Supplements – Zinc. https://ods.od.nih.gov/factsheets/zinc-healthprofessional/. Accessed 24 Feb. 2026.
Ponce-Gallegos, Marco A., et al. “Genetic Variants in IL17A and Serum Levels of IL-17A Are Associated with COPD Related to Tobacco Smoking and Biomass Burning.” Scientific Reports, vol. 10, no. 1, Jan. 2020, p. 784. PubMed, https://doi.org/10.1038/s41598-020-57606-6.
Ren, Wei, et al. “Polymorphisms in the IL-17 Gene (Rs2275913 and Rs763780) Are Associated with Hepatitis B Virus Infection in the Han Chinese Population.” Genetic Testing and Molecular Biomarkers, vol. 21, no. 5, May 2017, pp. 286–91. PubMed, https://doi.org/10.1089/gtmb.2016.0177.
Rolandelli, A., et al. “The IL-17A Rs2275913 Single Nucleotide Polymorphism Is Associated with Protection to Tuberculosis but Related to Higher Disease Severity in Argentina.” Scientific Reports, vol. 7, Jan. 2017, p. 40666. PubMed, https://doi.org/10.1038/srep40666.
Silva, Milca de J., et al. “Variants in the IL17 Pathway Genes Are Associated with Atopic Asthma and Atopy Makers in a South American Population.” Allergy, Asthma, and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology, vol. 15, 2019, p. 28. PubMed, https://doi.org/10.1186/s13223-019-0340-7.
Song, Mi Hye, et al. “Vitamin C Enhances the Expression of IL17 in a Jmjd2–Dependent Manner.” BMB Reports, vol. 50, no. 1, 2017, pp. 49–54. PubMed Central, https://doi.org/10.5483/BMBRep.2017.50.1.193.
Xie, Lin, et al. “Amelioration of Experimental Autoimmune Encephalomyelitis by Curcumin Treatment through Inhibition of IL-17 Production.” International Immunopharmacology, vol. 9, no. 5, May 2009, pp. 575–81. PubMed, https://doi.org/10.1016/j.intimp.2009.01.025.
Yan, Ni, et al. “Association of Interleukin-17A and -17F Gene Single-Nucleotide Polymorphisms with Autoimmune Thyroid Diseases.” Autoimmunity, vol. 45, no. 7, Nov. 2012, pp. 533–39. PubMed, https://doi.org/10.3109/08916934.2012.702814.
———. “Association of Interleukin-17A and -17F Gene Single-Nucleotide Polymorphisms with Autoimmune Thyroid Diseases.” Autoimmunity, vol. 45, no. 7, Nov. 2012, pp. 533–39. PubMed, https://doi.org/10.3109/08916934.2012.702814.
Zacarias, Joana Maira Valentini, et al. “The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients.” Mediators of Inflammation, vol. 2015, 2015, p. 147056. PubMed, https://doi.org/10.1155/2015/147056.
Zhai, Cui, et al. “Association of Interleukin-17a Rs2275913 Gene Polymorphism and Asthma Risk: A Meta-Analysis.” Archives of Medical Science: AMS, vol. 14, no. 6, Oct. 2018, pp. 1204–11. PubMed, https://doi.org/10.5114/aoms.2018.73345.
Zhang, Xiaolin, et al. “Interleukin-17A Gene Variants and Risk of Coronary Artery Disease: A Large Angiography-Based Study.” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 412, nos. 3–4, Jan. 2011, pp. 327–31. PubMed, https://doi.org/10.1016/j.cca.2010.10.027.
Zhang, Xin, et al. “Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes.” Journal of Immunology (Baltimore, Md.: 1950), vol. 180, no. 10, May 2008, pp. 6988–96. PubMed, https://doi.org/10.4049/jimmunol.180.10.6988.

About the Author:
Debbie Moon is a biologist, engineer, author, and the founder of Genetic Lifehacks where she has helped thousands of members understand how to apply genetics to their diet, lifestyle, and health decisions. With more than 10 years of experience translating complex genetic research into practical health strategies, Debbie holds a BS in engineering from Colorado School of Mines and an MSc in biological sciences from Clemson University. She combines an engineering mindset with a biological systems approach to explain how genetic differences impact your optimal health.